Levita Magnetics

What Levita Magnetics does

Levita Magnetics, Inc. is a privately-held medical device company founded in 2011 by minimally invasive surgeon Dr. Alberto Rodriguez-Navarro and headquartered in Mountain View, California, with an additional office in Santiago, Chile. The company develops the MARS (Magnetic-Assisted Robotic Surgery) platform, which combines proprietary Dynamic Magnetic Positioning technology — using external magnets to maneuver internal surgical instruments and retract organs without additional incisions — with robotic arms in a console-free, compact-footprint system designed for high-volume abdominal surgery. The platform received its first FDA clearance in 2016, with a subsequent MARS-specific 510(k) clearance in August 2023, and has since gained expanded indications for bariatric, hiatal hernia, and pediatric (ages 12+) procedures, supported by at least six issued US patents.

The company's customers are acute care hospitals, academic medical centers, and ambulatory surgical centers performing laparoscopic cholecystectomy, bariatric, colorectal, urological, and pediatric abdominal procedures, with named deployments at Cleveland Clinic, Stanford University Hospital, Duke, UT Southwestern, and a growing international presence in Chile. Revenue is generated through direct sale of the MARS system hardware and ongoing sales of proprietary magnetic instruments and consumables (including a 12.5mm magnetic grasper launched in 2025), with go-to-market driven by enterprise field sales targeting key opinion leader surgeons and a hybrid of US and international clinical reference sites. The company has raised approximately $35 million+ in venture funding across multiple rounds (including a $26 million Series C in August 2022) and is led by founder/CEO Dr. Rodriguez-Navarro with chairperson Maria Sainz, an experienced medtech operator.

Name

Levita Magnetics

Legal name

Levita Magnetics, Inc.

Website

https://levita.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Healthcare & Assistive Robotics (HDAAAIAC), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Magnetic surgical systems
• Robotic surgery platforms
• Minimally invasive surgery
• Laparoscopic surgical devices
• Magnetic-assisted retraction

Headquarters

HQ city

San Mateo

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device Sales - MARS System: Direct sale of the MARS surgical platform and Magnetic Surgical System to hospitals and ambulatory surgical centers. Revenue generated from device hardware, proprietary instruments, and related components. Sales to high-volume abdominal surgery departments at leading medical institutions.
2. Consumables and Accessories: Ongoing revenue from specialized magnetic graspers and instruments used with the platform. New 12.5mm magnetic grasper released in 2025 for specific procedures.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Levita Magnetics develops and sells the MARS (Magnetic-Assisted Robotic Surgery) platform and Magnetic Surgical System, which use proprietary Dynamic Magnetic Positioning technology to allow surgeons to maneuver internal surgical instruments via external magnets. The platform reduces the number of incisions required in laparoscopic abdominal surgeries, offers an AI-guided autonomous camera, and is compatible with AR headsets (Meta Quest 3, Apple Vision Pro) and Da Vinci robotic systems. The system is sold to hospitals, academic medical centers, and ambulatory surgery centers for procedures including bariatric, colorectal, gallbladder, prostate, hiatal hernia, and pediatric surgeries.

Differentiator

Problem solved

Functional benefit

Brands

• Magnetic Surgery: The company's proprietary magnetic surgical technology platform that uses external magnets to control internal surgical instruments, reducing the number of incisions required in laparoscopic procedures.
• MARS (Magnetic-Assisted Robotic Surgery)
• Dynamic Magnetic Positioning

Products and services

• Magnetic Surgical System (MSS) First-generation magnetic surgical platform using external magnets to control internal surgical instruments, reducing the number of incisions required in laparoscopic procedures. Initially indicated for gallbladder removal.
• MARS (Magnetic-Assisted Robotic Surgery) Platform First-of-its-kind minimally invasive surgery platform combining magnets and machines, featuring dual surgeon-controlled arms for full control over the laparoscopic view and magnetic retractor, with a console-free compact footprint designed for high-volume outpatient abdominal surgeries.
• 12.5mm Magnetic Grasper Specialized magnetic grasper instrument for the MARS system, designed for patients with high BMI and challenging anatomy, used in bariatric and hiatal hernia procedures to grasp the liver more centrally.
• Pediatric Indication for MARS / Magnetic Surgical System FDA-cleared extension of the Magnetic Surgical System (MSS) and MARS platform for pediatric patients (ages 12+) within a BMI range of 20-34 kg/m², for laparoscopic cholecystectomy procedures.
• AI-Guided Autonomous Surgical Camera AI-integrated autonomous camera module for the MARS platform that uses computer vision on the surgical video feed to automatically maintain optimal visualization of the surgical field, eliminating the need for a camera assistant.

Quantifiable outcome

• Patients return to work within 5 days of surgery on average
• +4 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• StrykercoreTechnology or Integration · 10 September 2025Integration partnership using Stryker 1788 4K camera with MARS platform for AI-guided autonomous surgery. The AI-guided MARS system incorporated Stryker's latest-generation 4K camera providing enhanced visualization of the surgical field.
• Intuitive Surgical (Da Vinci SP)coreTechnology or Integration · 11 December 2024Dual-system surgery combining MARS platform with Da Vinci Single Port robot. First-ever surgery utilizing two distinct robotic systems together, demonstrating platform interoperability.
• B. Braun AesculapcoreTechnology or Integration · 24 October 2024Partnership using B. Braun Aesculap EinsteinVision 3D camera with MARS robotic platform and Meta Quest 3 for augmented reality surgeries. Enabled unprecedented improvement in surgical visualization.
• Meta (Meta Quest 3)coreTechnology or Integration · 20 March 2024Integration of Meta Quest 3 AR headset with MARS system for augmented reality abdominal surgeries. First clinical case integrating Magnetic Surgery, machines, and AR technology. Software can also be used with Apple Vision Pro.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Intuitive Surgical: Maker of the Da Vinci surgical robotics platform — the dominant incumbent in robotic-assisted minimally invasive surgery. Directly relevant as Levita's primary competitor and integration partner (MARS paired with Da Vinci SP at UT Southwestern), serving the same abdominal surgery market.
• Medtronic: Healthcare conglomerate with the Hugo robotic-assisted surgery system competing in the same minimally invasive abdominal surgery market. Broad incumbent with massive commercial infrastructure, hospital relationships, and capital resources that dwarf Levita's scale.
• Johnson & Johnson (Ethicon): Medical device giant developing the Ottava robotic surgery platform while owning a leading surgical instruments franchise (Ethicon) used in laparoscopic procedures. Represents both a potential competitor and a strategic acquirer or partner for Levita.
• Stryker: Major surgical device and orthopedic robotics company (Mako) that is also a Levita integration partner via the Stryker 1788 4K camera. Comparable as a broad incumbent in surgical visualization and robotics, and a strategic relationship that supports Levita's AI-guided autonomy narrative.

Direct peers

• CMR Surgical: Developer of the Versius surgical robotic system for minimally invasive laparoscopic procedures. Directly comparable as a next-generation robotic surgery platform targeting similar abdominal and general surgery use cases, though Versius uses a modular multi-port approach versus Levita's magnetic positioning.

Emerging players

• Moon Surgical: Emerging surgical robotics company developing a compact, console-adjacent robotic-assisted platform for laparoscopic surgery. Comparable to Levita as a smaller, well-funded European peer pursuing a similar vision of bringing robotics to high-volume abdominal surgery in a more accessible form factor.
• Asensus Surgical: Developer of the Senhance surgical system with a focus on digital laparoscopy and machine-vision-enabled surgical assistance. Comparable as an emerging peer pursuing AI-enabled surgical capabilities similar to Levita's autonomous camera direction.
• Virtual Incision: Developer of the MIRA miniaturized robotic-assisted surgery platform targeting colon resection and other abdominal procedures. Comparable as a smaller emerging player in surgical robotics pursuing differentiated approaches to minimally invasive abdominal surgery.
• Vicarious Surgical: Developer of a single-incision robotic surgery platform with VR surgeon visualization for abdominal procedures. Comparable as a capital-constrained emerging peer pursuing novel surgical robotics architectures for similar abdominal use cases.

Others

• B. Braun: Major medical device manufacturer and Levita integration partner via the Aesculap EinsteinVision 3D camera. Relevant as an established surgical visualization and instruments player that is also a collaborating ecosystem partner for Levita's AR-enhanced surgery work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/levitamagnetics
• LinkedInlinkedin.com/company/levita-magnetics

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds10 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Levita Magnetics